Long-term androgen priming by use of dehydroepiandrosterone (DHEA) improves IVF outcome in poor-responder patients. A randomized controlled study

Middle East Fertility Society Journal

Volumn 17, Issue 4, 2012, Pages 268-274

  Moawad, Ashraf ^a,b   Shaeer, Mahmoud ^b  

^a Al Azhar Medical School   (United Arab Emirates)

^b IVF Unit   (United Arab Emirates)

Author keywords

DHEA; IVF; Poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; PRASTERONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CONTROLLED OVARY HYPERSTIMULATION; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84871819440     PISSN: 11105690     EISSN: 20903251     Source Type: Journal    
DOI: 10.1016/j.mefs.2012.11.002     Document Type: Article

References (40)

1. E.S. Surrey, and W.B. Schoolcraft Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques Fertil Steril 73 2000 667 676
2. S. Fasouliotis, A. Simon, and N. Laufer Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet J Assist Reprod Genet 17 2000 357 373
3. S. Shanbhag, L. Aucott, S. Bhattacharya, M.A. Hamilton, and A.R. McTavish Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst Rev 24 2007 CD004379
4. C. Kailasam, S.D. Keay, P. Wilson, W.C. Ford, and J.M. Jenkins Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome Hum Reprod 19 2004 1544 1547
5. J.L. Frattarelli, M.J. Hill, G.D. McWilliams, K.A. Miller, P.A. Bergh, and R.T. Scott Jr. A luteal estradiol protocol for expected poor-responders improves embryo number and quality Fertil Steril 89 2008 1118 1122
6. U. Ulug, I. Ben-Shlomo, E. Turan, H.F. Erden, M.A. Akman, and M. Bahceci Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles Reprod Biomed Online 6 2003 439 443
7. K.A. Mohamed, W.A. Davies, J. Allsopp, and H. Lashen Agonist 'flare-up' versus antagonist in the management of poor responders undergoing in vitro fertilization treatment Fertil Steril 83 2005 331 335
8. D.W. Schmidt, T. Bremner, J.J. Orris, D.B. Maier, C.A. Benadiva, and J.C. Nulsen A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders Fertil Steril 83 2005 1568 1571
9. T. Kucuk, H. Kozinoglu, and A. Kaba Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial J Assist Reprod Genet 25 2008 123 127
10. D. Kyrou, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, J. Bontis, and B.C. Tarlatzis How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Fertil Steril 91 2009 749 766
11. B. Vollenhoven, T. Osianlis, and J. Catt Is there an ideal stimulation regimen for IVF for poor responders and does it changes with age? J Assist Reprod Genet 25 2008 523 529
12. J.N. Hugues Impact of androgen on fertility-physiological, clinical and therapeutical aspects Reprod Biomed Online 11 2005 570 580
13. C.S. Rani, A.R. Salhanick, and D.T. Armstrong Follicle-stimulating hormone induction of luteinizing hormone receptor in cultured rat granulosa cells: an examination of the need for steroids in the induction process Endocrinology 108 1981 1379 1385
14. H.J. Shaw, S.G. Hillier, and J.K. Hodges Developmental changes in luteinizing hormone/human chorionic gonadotropin steroidogenic responsiveness in marmoset granulosa cells: effects of follicle-stimulating hormone and androgens Endocrinology 124 1989 1669 1677
15. K. Lossl, C. Yding Andersen, A. Loft, N.L. Freiesleben, S. Bangsbøll, and A. Nyboe Andersen Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial Hum Reprod 23 2008 1820 1829
16. J. Balasch, F. Fábregues, J. Peñarrubia, F. Carmona, R. Casamitjana, and M. Creus Pretreatment with transdermal testosterone may improve ovarian response to gonadotropins in poor-responder IVF patients with normal basal concentrations of FSH Hum Reprod 21 2006 1884 1893
17. D. Barad, and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Hum Reprod 21 2006 2845 2849
18. N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.N. Hugues Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study Hum Reprod 21 2006 1204 1211
19. C.I. Durnerin, K. Erb, R. Fleming, H. Hillier, S.G. Hillier, and C.M. Howles Luveris pretreatment group. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation Hum Reprod 23 2008 421 426
20. H.G. Burger Androgen production in women Fertil Steril 77 Suppl. 4 2002 S3 S5
21. P.R. Casson, M.S. Lindsay, M.D. Pisarska, S.A. Carson, and J.E. Buster Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series Hum Reprod 15 2002 2129 2132
22. A.J. Harper, J.E. Buster, and P.R. Casson Changes in adrenocortical function with aging and therapeutic implications Semin Reprod Endocrinol 17 1999 327 338
23. S.G. Hillier, P.F. Whitelaw, and C.D. Smyth Follicular estrogen synthesis: the '2-cell, two-gonadotrophin' model revisited Mol Cell Endocrinol 100 1994 51 54
24. P.R. Casson, N. Santoro, K. Elkind-Hirsch, S.A. Carson, P.J. Hornsby, and G. Abraham Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial Fertil Steril 70 1998 107 110
25. H. Amirikia, R.T. Savoy-Moore, A.S. Sundareson, and K.S. Moghissi The effects of long-term androgen treatment on the ovary Fertil Steril 45 1986 202 208
26. D. Barad, and N. Gleicher Increased oocyte production after treatment with dehydroepiandrosterone Fertil Steril 84 2005 756
27. K. Lossl, A.N. Andersen, A. Loft, N.L. Freiesleben, S. Bangsbøll, and C.Y. Andersen Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols Hum Reprod 21 2006 2593 2600
28. A. Wiser, O. Gonen, Y. Ghetler, T. Shavit, A. Berkovitz, and A. Shulman Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study Hum Reprod 25 10 2010 2496 2500
29. A. Moawad, A.E. Hanan, and M. Shaeer Early follicular anti-mullerian hormone as a predictor of ovarian response during ICSI cycles Middle East Fertil Soc J 15 4 2010 281 287
30. D. Barad, H. Brill, and N. Gleicher Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function J Assist Reprod Genet 24 2007 629 634
31. L. Mamas, and E. Mamas Premature ovarian failure and dehydroepiandrosterone Fertil Steril 91 2009 644 646
32. R. Kaaks, F. Berrino, T. Key, S. Rinaldi, L. Dossus, and C. Biessy Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst 97 2005 755 765
33. H.D. McClamrock, and E.Y. Adashi Gestational hyperandrogenism Fertil Steril 57 1992 257 274
34. T. Sir-Petermann, M. Maliqueo, B. Angel, H.E. Lara, F. Perez-Bravo, and S.E. Recabarren Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization Hum Reprod 17 2002 2573 2579
35. P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, and R.F. Frye DHEA and DHEA-S: a review J Clin Pharmacol 39 1999 327 348
36. J.H. Hyman, E.J. Margalioth, R. Rabinowitz, A. Tsafrir, N. Algur, and T. Eldar-Geva Dehydroepiandrosterone (DHEA) supplementation for poor responders-how does it work? Fertil Steril 94 Suppl. 4 2010 S86
37. N. Gleicher, A. Goyal, A. Weghofer, and D.H. Barad Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-müllerian hormone levels Fertil Steril 92 Suppl. 3 2009 S54 S55
38. D.H. Barad, and A. Kim Effects of dehydroepiandrosterone (DHEA) in women with diminished ovarian reserve (DOR) on functional ovarian reserve in 3 consecutive IVF cycles, as assessed by oocyte yields and pregnancy rates Fertil Steril 96 Suppl. 3 2011 S263
39. E.L. Motta, L.M. Rossi, T.R. Fernandes, A.A. Massaguer, G. Fassolas, and P. Serafini The use of DHEA in poor responders does not improve IVF outcomes: insights of a pilot study Fertil Steril 86 Suppl. 3 2006 S428
40. N. Gleicher, E. Ryan, A. Weghofer, K. Oktay, S. Blanco-Mejia, and D.H. Barad Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminished ovarian reserve: a multicenter study Fertil Steril 90 Suppl. 1 2008 S258 S259